Ganner A, Gehrke C, Klein M, Thegtmeier L, Matulenski T, Wingendorf L, et al. VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. Sci Rep. 2021;11:14827 pubmed publisher

Chawsheen M, Dash P. mTOR modulates resistance to gemcitabine in lung cancer in an MTORC2 dependent mechanism. Cell Signal. 2021;81:109934 pubmed publisher

Seo S, Woo S, Lee H, Kim S, Min K, Kwon T. mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy. Oncogene. 2018;37:5205-5220 pubmed publisher

Liu D, Ceddia R, Collins S. Cardiac natriuretic peptides promote adipose 'browning' through mTOR complex-1. Mol Metab. 2018;9:192-198 pubmed publisher

Manifava M, Smith M, Rotondo S, Walker S, Niewczas I, Zoncu R, et al. Dynamics of mTORC1 activation in response to amino acids. elife. 2016;5: pubmed publisher

Carbonneau M, M Gagné L, Lalonde M, Germain M, Motorina A, Guiot M, et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun. 2016;7:12700 pubmed publisher

Hao F, Itoh T, Morita E, Shirahama Noda K, Yoshimori T, Noda T. The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity. FEBS Lett. 2016;590:161-73 pubmed publisher

Robles Molina E, Dionisio Vicuña M, Guzmán Hernández M, Reyes Cruz G, Vazquez Prado J. G?? interacts with mTOR and promotes its activation. Biochem Biophys Res Commun. 2014;444:218-23 pubmed publisher

Sarbassov D, Ali S, Kim D, Guertin D, Latek R, Erdjument Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004;14:1296-302 pubmed